Global Oral Proteins and Peptides Competitive Landscape Professional Research Report 2024
Research Summary
Oral proteins and peptides are biologically active molecules that are administered through oral ingestion, allowing them to be absorbed and exert their therapeutic effects within the human body. These substances can include proteins, peptides, and antibodies designed to treat various medical conditions. Developing effective oral protein and peptide formulations is a significant challenge due to the digestive processes in the gastrointestinal tract. However, research and innovations in drug delivery technologies, such as nanoparticles, oral capsules, and mucoadhesive formulations, have expanded the possibilities of oral administration for these therapeutic molecules. This approach offers the advantage of non-invasive drug delivery and enhanced patient compliance, particularly for long-term treatments, as it eliminates the need for injections or intravenous infusions. It has the potential to revolutionize the treatment of conditions ranging from diabetes to autoimmune diseases, offering more convenient and patient-friendly options for managing various medical disorders.
According to DIResearch's in-depth investigation and research, the global Oral Proteins and Peptides market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharma, Novartis, Amryt Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Oral Proteins and Peptides. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Proteins and Peptides market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Proteins and Peptides market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Proteins and Peptides industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Proteins and Peptides Include:
Ironwood & Allergan
Novo Nordisk
Synergy Pharma
Novartis
Amryt Pharma
Oral Proteins and Peptides Product Segment Include:
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Oral Proteins and Peptides Product Application Include:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oral Proteins and Peptides Industry PESTEL Analysis
Chapter 3: Global Oral Proteins and Peptides Industry Porter’s Five Forces Analysis
Chapter 4: Global Oral Proteins and Peptides Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Oral Proteins and Peptides Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oral Proteins and Peptides Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources